Business Wire

JUVENESCENCE Appoints Dr Richard Marshall CBE as CEO

Share

Juvenescence has named Dr Richard Marshall CBE as its new CEO, effective 16 January 2023. Dr Marshall succeeds co-founder Dr Gregory Bailey, who will remain on the company’s board as Executive Chairman.

Dr Marshall brings over twenty years of business leadership to the company, with fifteen years at GSK culminating in his position as Vice President, Head of the Fibrosis & Lung Injury Discovery Performance Unit (DPU). Most recently, Dr Marshall was Senior Vice President, Global Development Head, Respiratory & Immunology of AstraZeneca. Dr Marshall was awarded a CBE in the 2021 Queen’s Honours List for his contribution to UK science and COVID-19.

“I am delighted that Dr Richard Marshall CBE, the former Senior Vice-President, Global Head of Development, Respiratory & Immunology at AstraZeneca, has agreed to lead Juvenescence as CEO. Throughout his career, Richard has been the architect of numerous transformative R&D strategies to drive innovation and deliver rapid growth, with a track record of collegial success, building high performing teams and developing novel therapies,” outgoing CEO Dr Gregory Bailey said. “Richard is a results-oriented leader who believes that in a post-COVID-19 world facing the impending crisis of an inverted demographic pyramid coupled with undercapitalized pension funds and ever-increasing healthcare costs, proactive, decentralized solutions are desperately needed. Juvenescence is a critical player in the mega-trends now driving towards the healthier lifestyles and digital health strategies needed to confront these issues. I am confident that with this appointment, we have a world class team with the experience and skillset to position Juvenescence as one of the premier biotech and pharmaceutical companies focused on modifying aging through prevention.

Dr Richard Marshall CBE said, “I am thrilled to be joining Juvenescence at such a pivotal point in the company’s history. They are at a real inflection point, with an incredible opportunity to build on Juvenescence’s trusted brand and the Founders’ 30-year history of developing drugs to bring innovative approaches to modify and prevent the impact of aging to the market. With its broad portfolio and depth of experience, Juvenescence is building a unique ecosystem of key partnerships and acquiring the critical capabilities needed for success in this rapidly evolving field. I look forward to working with the team, our partners, and shareholders to capitalize on this incredible opportunity.

About Juvenescence

Juvenescence is a life sciences company developing therapies to modify aging and increase healthy human lifespan. It was founded by Jim Mellon, Dr Greg Bailey and Dr Declan Doogan. The Juvenescence team consists of highly experienced drug developers, entrepreneurs, marketers, and investors with a significant history of success in pharmaceutical drug development, synthetic biology, and tissue and cellular engineering.

Juvenescence has a broad portfolio of products in development and is driving innovation, with a focus on discovering and developing these therapies to modify the aging process, through prevention and by regenerating damage, to support healthy aging and increase health span. The company is committed to inspiring and equipping the world to, not just reimagine what it means to age, but to help people Reimagine A Lifetime. For more information see: www.JuvLabs.com

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

juvenescenceir@juvlabs.com

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

RevBits Endpoint Security Fully and Successfully Deployed, in a government-based entity PoC, for a True Air-Gapped Environment6.2.2023 15:30:00 CET | Press release

RevBits announces that it has successfully deployed its endpoint security solution in a true air-gapped environment for a federal government entity. RevBits Endpoint Security (RB/EPS) is a fully featured, robust next-generation endpoint security solution. Its detection and blocking capabilities are based on a three-phased analysis engine that utilizes traditional AV signature scanning, a sophisticated machine learning model, and an advanced behavioral analysis protocol. The solution's Phoenix module monitors for common exploit methods to provide additional protection. The solution's EDR module enhances endpoint security and threat mitigation, offering the market the most feature-rich forensics and control capability imaginable. Malicious endpoint investigations are limitless, with a forensics selection menu of over seventy different artifacts collected on schedule or demand and partial and full memory dumps. US Patented technology in the EDR module offers Windows kernel-level security

Rimini Street to Report Fourth Quarter and Fiscal Year 2022 Financial Results on March 1, 20236.2.2023 15:01:00 CET | Press release

Rimini Street, Inc. (Nasdaq: RMNI), a global provider of enterprise software products and services, the leading third-party support provider for Oracle and SAP software products and a Salesforce partner, today announced it will report earnings after the market close on March 1, 2023. The Company will host a conference call and webcast on that date to discuss the fourth quarter and fiscal year 2022 results, and the 2023 outlook, at 5:00 p.m. Eastern / 2:00 p.m. Pacific time. A live webcast of the event will be available on Rimini Street’s Investor Relations site at https://investors.riministreet.com/news-events/events. Dial-in participants can access the conference call by dialing (888) 999-2501 or (848) 280-6480. A replay of the webcast will be available for one year following the event. About Rimini Street, Inc. Rimini Street, Inc. (Nasdaq: RMNI), a Russell 2000® Company, is a global provider of enterprise software products and services, the leading third-party support provider for Or

Taulia Signs Memorandum of Understanding With Aramco to Explore Supplier Financing Solutions6.2.2023 11:45:00 CET | Press release

Taulia, a leading provider of working capital management solutions, today announces it has signed a Memorandum of Understanding (MoU) with Aramco, one of the world's leading integrated energy and chemicals companies, to discuss Taulia providing supplier financing solutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230206005330/en/ As part of its In-Kingdom Total Value Add (iktva) program, which strives to accelerate digital transformation efforts domestically, Aramco recently signed over 100 agreements to help advance a diverse, sustainable and globally competitive industrial ecosystem (please see here for further details). Taulia is undertaking the program in collaboration with J.P. Morgan and Manafa Capital. Cedric Bru, CEO of Taulia, comments: “Through this program, we are paving the way for thousands of businesses worldwide to access affordable financing options and manage their liquidity as they continue to naviga

Ambassador Carlos dos Santos appointed as Executive Chairman of Compass Group Holdings.6.2.2023 10:49:00 CET | Press release

Compass Group Holdings, a leading Energy Project Management, and Integrated Services company operating in East Africa, and headquartered in Maputo, Mozambique, is delighted to announce the appointment of Ambassador Carlos dos Santos to the Board as Executive Chairman with immediate effect. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230206005124/en/ Ambassador Carlos dos Santos appointed as Executive Chairman of Compass Group Holdings. (Photo: Business Wire) Ambassador Carlos dos Santos is a career Diplomat with distinctive business experience and most recently served as The Ambassador of Mozambique to the United States and High Commissioner for Canada (2015-2022). Prior to this prominent role, his extensive and renowned career included serving as the High Commissioner for the United Kingdom, Ambassador to Ireland and Governor at the Commonwealth Board of Governors (2011-2015), and Ambassador of Mozambique to Germany, Aus

SYNTAGMA CAPITAL enters into exclusive negotiations to acquire Nexans’ LAN/data center (“LAN/DC”) and Telecom /Fibre (“FTTx”) division.6.2.2023 08:30:00 CET | Press release

Syntagma Capital today announces that it has entered into exclusive negotiations with Nexans SA to acquire its LAN/data center (“LAN/DC”) and Telecom /Fibre (“FTTx”) division. The business designs, manufactures, and distributes smart connectivity solutions based on optical fibre and copper technologies to data centers, smart buildings, and telecom operators. The business is headquartered in Paris, France and employs ca. 680 people across its 8 sites located in France, Belgium, Germany, Greece, Morocco and China, and it generated ca. €200m in revenues across 100+ countries. The proposed transaction, which is subject to the fulfillment of customary closing conditions, including the information and consultation of works councils and other regulatory approvals, is expected to be completed by the end of the first half of 2023. “We are pleased to partner with management to continue to grow the business. Providing the backbone for data management is an exciting prospect. Despite a challenging